Hello, I'm Greg Jenna and good news, Your Dead to Me is back for a new series. Here we go. Yes, we'll explore Emperor Nero's notorious reign with Professor Marybeard and Patton Oswald. I would not want my daughter having the remote control, not alone an empire. We'll dissect the decadent life of Philippe Duke-Dor-Leon with Tom Allen. I've often tried to pretend I'm an aristocrat and being very

quickly knocked down. And there'll be so much more with comedians like Olga Koch, Mike Mosniak and Rihalina.

I'm excited. You're dead to me, the comedy podcast that takes history seriously. Listen first on BBC Sounds.

Hello, I'm Dr Mark Porter and thank you for downloading this edition of Inside Health.

I hope you enjoy it.

Healthcare is riddled with conflicts of interest,

but most of us, whether clinician or patient,

remain blissfully unaware of their existence.

You've got to accept that if somebody is funding your research,

that is likely to influence your thinking in some way, however small,

there's a real danger.

In the first programme of this three-part series on Conflict of Interest, we heard from

campaigners questioning the independence of leading authorities in the medical world

and the expert advisory committees they so often sit on.

This week, we're going to explore other hidden influences that may affect how your GP or specialist treats you. The problem

for general practice is that every day we are living with conflicts of interest. And we reveal the

hidden vested interests behind some of the patient groups to whom you may turn for advice and support.

We feel that by not taking money from industry, we maintain our impartiality.

We're free to voice an opinion. We're completely unbiased.

And ultimately, we're able to give women a balanced view on any issues affecting them.

Part of a patient group's role is to lobby for new and improved treatments,

like the drug Heseptin, heralded as a major breakthrough in breast cancer therapy

...